We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current TAK market cap is 41.44B. The company's latest EPS is JPY 45.9101 and P/E is 1.07.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Total Revenue | 962.81B | 1.06T | 1.05T | 1.11T | -2.62T |
Operating Income | 85.67B | 168.15B | -47.32B | 106.04B | -310.99B |
Net Income | 31.13B | 89.4B | -48.03B | 105.72B | 191.79B |
Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Total Revenue | 3.35T | 3.28T | 3.61T | 4.05T | 4.28T |
Operating Income | 70.72B | 275.69B | 438.73B | 479.78B | 220.41B |
Net Income | 44.24B | 376.01B | 230.06B | 317.02B | 144.07B |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Total Assets | 13.96T | 14.79T | 14.87T | 14.22T | 9.76T |
Total Liabilities | 7.6T | 7.87T | 7.8T | 7.48T | 5.67T |
Total Equity | 6.35T | 6.92T | 7.07T | 6.74T | 4.09T |
Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Total Assets | 12.82T | 12.91T | 13.18T | 13.96T | 15.11T |
Total Liabilities | 8.09T | 7.74T | 7.49T | 7.6T | 7.83T |
Total Equity | 4.73T | 5.18T | 5.68T | 6.35T | 7.27T |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Operating | 977.16B | 92.4B | 291.3B | 437.76B | N/A |
Investing | -607.1B | -266.52B | -327.11B | -402.38B | N/A |
Financing | -709.15B | -57.78B | -198.43B | -296.19B | N/A |
Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Operating | 669.75B | 1.01T | 1.12T | 977.16B | 716.34B |
Investing | 292.12B | 393.53B | -198.13B | -607.1B | -463.86B |
Financing | -1.01T | -1.09T | -1.07T | -709.15B | -354.42B |
Market Cap | 41.44B |
Price to Earnings Ratio | 1.07 |
Price to Sales Ratio | 0.04 |
Price to Cash Ratio | 0.34 |
Price to Book Ratio | 0.02 |
Dividend Yield | 4.68% |
Shares Outstanding | 3.14B |
Average Volume (1 week) | 1.5M |
Average Volume (1 Month) | 1.6M |
52 Week Change | -6.48% |
52 Week High | 15.08 |
52 Week Low | 12.575 |
Spread (Intraday) | 0.01 (0.08%) |
Company Name | Takeda Pharmaceutical Company Ltd |
Address |
4-1-1 doshomachi chuo, tokyo 540-8645 |
Website | https://www.takeda.co.jp |
Industry | pharmaceutical diversified (H2) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions